Javier
Cañueto Álvarez
Profesor Asociado CC. Salud
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (7)
2024
-
Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data
Journal of the European Academy of Dermatology and Venereology
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64
-
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study
Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
2020
-
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 4, pp. 762-768
2018
-
First-line treatment in lymphomatoid papulosis: a retrospective multicentre study
Clinical and Experimental Dermatology, Vol. 43, Núm. 2, pp. 137-143